Placenta-derived multipotent stem cells
First Claim
1. A method for treating spina bifida in a subject in need thereof comprising administering to the subject an effective amount of an isolated pre-term placenta-derived multipotent stem cell or cells (PMSCs) or culture conditioned media therefrom.
1 Assignment
0 Petitions
Accused Products
Abstract
This disclosure provides isolated cells and compositions comprising one or more isolated cell(s) as described herein. In one aspect, the isolated cell is a pre-term placenta-derived stem cell (also referred to placenta-derived multi potent stem cells (pmSCs). As used herein, the term “pre-term placenta-derived multipotent stem cell or placenta-derived stem cells” intends a cell isolated from placental tissue prior to delivery of the fetus by surgery or birth. In another aspect, the isolated cell is a chorionic villus (CV)-derived multipotent placental stem cells (C-mpSCs). Also provided are compositions comprising these cells, wherein the composition comprises an effective amount of the isolated cells as described herein.
4 Citations
13 Claims
- 1. A method for treating spina bifida in a subject in need thereof comprising administering to the subject an effective amount of an isolated pre-term placenta-derived multipotent stem cell or cells (PMSCs) or culture conditioned media therefrom.
Specification